Takeda Pharmaceutical Company Limited
Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions

Last updated:

Abstract:

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

26 Nov 2014

Issue date:

18 Feb 2020